Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe page removes the 'Multiple myeloma' label and the related topic entry 'MedlinePlus Genetics', reducing explicit disease context and associated educational resources displayed for the study.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded 'Multiple myeloma' and a 'MedlinePlus Genetics' related topics link, and updated the site revision from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page no longer displays the explicit disease name and drops the related topics block, altering how the study topic and linked resources are presented on the study details page.SummaryDifference0.1%

- Check32 days agoChange DetectedA new 'Multiple myeloma' label and a 'related topics' section including MedlinePlus Genetics were added, and the site revision was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check40 days agoChange DetectedThe study record now shows completed status with actual dates, replacing the previous Active, not recruiting status, and the page revision has been updated to v3.6.2. This reflects that enrollment is closed and the study timeline milestones have been updated.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study details page no longer shows the disease term 'Multiple myeloma' or the related topics section (including MedlinePlus Genetics). This removes disease-specific context and related-resource links from the page.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.